Clinical Trials Logo

Sleep Inertia clinical trials

View clinical trials related to Sleep Inertia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04975360 Completed - Caffeine Clinical Trials

Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening

Start date: February 8, 2019
Phase: N/A
Study type: Interventional

Sleep inertia (sometimes also referred to as sleep drunkenness) is a disabling state of increased sleepiness, impaired mood and reduced vigilance immediately upon awakening. Sleep inertia is highly prevalent in various neurological diseases, including neurodegenerative, affective and circadian sleep-wake rhythms disorders, as well as in frequent societal conditions such as chronic sleep restriction, jetlag and shiftwork. Reactive countermeasures against sleep inertia, i.e., strategies implemented upon wake-up, are not sufficiently effective, yet current recommendations are limited to proactive strategies, including long enough sleep at optimal times of day. These recommendations are not always easy and sometimes impossible to apply. To address this unmet medical need, the investigators developed an innovative, time-controlled, pulsatile-release formulation of 160 mg caffeine targeting an efficacious dose briefly before planned awakening.